Tilde Sciences acquires Daraprim® and Vecamyl® from Vyera Pharmaceuticals
/PRNewswire/ -- Tilde Sciences, a specialty pharmaceutical company, announced today that it has acquired two medicines, Daraprim® and Vecamyl® from Vyera...
United States Tilde Sciences Vyera Pharmaceuticals Prnewswire Tilde Sciences Optime Care Tilde Sciences Llc
Source: prnewswire.com